APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Alcoholic Hepatiti Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Alcoholic Hepatiti Drug Industry Growth and Trends Forecast to 2032

Report ID 173961640122 December 202596 pages

Choose your research edition.

Industry ResearchAlcoholic Hepatiti Drug Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Alcoholic Hepatiti Drug Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Alcoholic Hepatiti Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Alcoholic Hepatiti Drug Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Alcoholic Hepatiti Drug Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Alcoholic Hepatiti Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Alcoholic Hepatiti Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Alcoholic Hepatiti Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Alcoholic Hepatiti Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Alcoholic Hepatiti Drug include Vital Therapies Inc, Verlyx Pharma Inc, Promethera Biosciences SA, Intercept Pharmaceuticals Inc, Immuron Ltd, GRI Bio Inc, Gilead Sciences Inc, Generon (Shanghai) Corp Ltd and Alfact Innovation, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Alcoholic Hepatiti Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Alcoholic Hepatiti Drug market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Alcoholic Hepatiti Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Alcoholic Hepatiti Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Alcoholic Hepatiti Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Alcoholic Hepatiti Drug Market by Company

Vital Therapies Inc

Verlyx Pharma Inc

Promethera Biosciences SA

Intercept Pharmaceuticals Inc

Immuron Ltd

GRI Bio Inc

Gilead Sciences Inc

Generon (Shanghai) Corp Ltd

Alfact Innovation

Alcoholic Hepatiti Drug Segment by Type

IMM-124E

HepaStem

GRI-0621

F-652

Others

Alcoholic Hepatiti Drug Segment by Application

Clinic

Hospital

Others

Alcoholic Hepatiti Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Alcoholic Hepatiti Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Alcoholic Hepatiti Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Alcoholic Hepatiti Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Alcoholic Hepatiti Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Alcoholic Hepatiti Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of IMM-124E Table 2. Major Company of HepaStem Table 3. Major Company of GRI-0621 Table 4. Major Company of F-652 Table 5. Major Company of Others Table 6. Global Alcoholic Hepatiti Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Alcoholic Hepatiti Drug Sales by Type (2021-2026) & (k units) Table 8. Global Alcoholic Hepatiti Drug Sales Market Share in Volume by Type (2021-2026) Table 9. Global Alcoholic Hepatiti Drug Sales by Type (2021-2026) & (US$ Million) Table 10. Global Alcoholic Hepatiti Drug Sales Market Share in Value by Type (2021-2026) Table 11. Global Alcoholic Hepatiti Drug Price by Type (2021-2026) & (US$/unit) Table 12. Global Alcoholic Hepatiti Drug Sales by Type (2027-2032) & (k units) Table 13. Global Alcoholic Hepatiti Drug Sales Market Share in Volume by Type (2027-2032) Table 14. Global Alcoholic Hepatiti Drug Sales by Type (2027-2032) & (US$ Million) Table 15. Global Alcoholic Hepatiti Drug Sales Market Share in Value by Type (2027-2032) Table 16. Global Alcoholic Hepatiti Drug Price by Type (2027-2032) & (US$/unit) Table 17. North America Alcoholic Hepatiti Drug Sales by Type (2021-2026) & (k units) Table 18. North America Alcoholic Hepatiti Drug Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Alcoholic Hepatiti Drug Sales by Type (2021-2026) & (k units) Table 20. Europe Alcoholic Hepatiti Drug Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Alcoholic Hepatiti Drug Sales by Type (2021-2026) & (k units) Table 22. Asia-Pacific Alcoholic Hepatiti Drug Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Alcoholic Hepatiti Drug Sales by Type (2021-2026) & (k units) Table 24. Latin America Alcoholic Hepatiti Drug Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Alcoholic Hepatiti Drug Sales by Type (2021-2026) & (k units) Table 26. Middle East and Africa Alcoholic Hepatiti Drug Sales by Type (2021-2026) & (US$ Million) Table 27. Alcoholic Hepatiti Drug Industry Trends Table 28. Alcoholic Hepatiti Drug Industry Drivers Table 29. Alcoholic Hepatiti Drug Industry Opportunities and Challenges Table 30. Alcoholic Hepatiti Drug Industry Restraints Table 31. Global Alcoholic Hepatiti Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Alcoholic Hepatiti Drug Revenue Market Share by Company (2021-2026) Table 33. Global Alcoholic Hepatiti Drug Sales by Company (2021-2026) & (k units) Table 34. Global Alcoholic Hepatiti Drug Sales Share by Company (2021-2026) Table 35. Global Alcoholic Hepatiti Drug Market Price by Company (2021-2026) & (US$/unit) Table 36. Global Alcoholic Hepatiti Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Alcoholic Hepatiti Drug Major Company Production Sites and Headquarters Table 38. Global Alcoholic Hepatiti Drug Company, Product Type & Application Table 39. Global Alcoholic Hepatiti Drug Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Alcoholic Hepatiti Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Alcoholic Hepatiti Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Alcoholic Hepatiti Drug Sales by Region (2021-2026) & (k units) Table 44. Global Alcoholic Hepatiti Drug Sales Market Share in Volume by Region (2021-2026) Table 45. Global Alcoholic Hepatiti Drug Sales by Region (2021-2026) & (US$ Million) Table 46. Global Alcoholic Hepatiti Drug Sales Market Share in Value by Region (2021-2026) Table 47. Global Alcoholic Hepatiti Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 48. Global Alcoholic Hepatiti Drug Sales by Region (2027-2032) & (k units) Table 49. Global Alcoholic Hepatiti Drug Sales Market Share in Volume by Region (2027-2032) Table 50. Global Alcoholic Hepatiti Drug Sales by Region (2027-2032) & (US$ Million) Table 51. Global Alcoholic Hepatiti Drug Sales Market Share in Value by Region (2027-2032) Table 52. Global Alcoholic Hepatiti Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 53. Global Alcoholic Hepatiti Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Alcoholic Hepatiti Drug Sales by Application (2021-2026) & (k units) Table 55. Global Alcoholic Hepatiti Drug Sales Market Share in Volume by Application (2021-2026) Table 56. Global Alcoholic Hepatiti Drug Sales by Application (2021-2026) & (US$ Million) Table 57. Global Alcoholic Hepatiti Drug Sales Market Share in Value by Application (2021-2026) Table 58. Global Alcoholic Hepatiti Drug Price by Application (2021-2026) & (US$/unit) Table 59. Global Alcoholic Hepatiti Drug Sales by Application (2027-2032) & (k units) Table 60. Global Alcoholic Hepatiti Drug Sales Market Share in Volume by Application (2027-2032) Table 61. Global Alcoholic Hepatiti Drug Sales by Application (2027-2032) & (US$ Million) Table 62. Global Alcoholic Hepatiti Drug Sales Market Share in Value by Application (2027-2032) Table 63. Global Alcoholic Hepatiti Drug Price by Application (2027-2032) & (US$/unit) Table 64. North America Alcoholic Hepatiti Drug Sales by Application (2021-2026) & (k units) Table 65. North America Alcoholic Hepatiti Drug Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Alcoholic Hepatiti Drug Sales by Application (2021-2026) & (k units) Table 67. Europe Alcoholic Hepatiti Drug Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Alcoholic Hepatiti Drug Sales by Application (2021-2026) & (k units) Table 69. Asia-Pacific Alcoholic Hepatiti Drug Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Alcoholic Hepatiti Drug Sales by Application (2021-2026) & (k units) Table 71. Latin America Alcoholic Hepatiti Drug Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Alcoholic Hepatiti Drug Sales by Application (2021-2026) & (k units) Table 73. Middle East and Africa Alcoholic Hepatiti Drug Sales by Application (2021-2026) & (US$ Million) Table 74. Vital Therapies Inc Company Information Table 75. Vital Therapies Inc Business Overview Table 76. Vital Therapies Inc Alcoholic Hepatiti Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 77. Vital Therapies Inc Alcoholic Hepatiti Drug Product Portfolio Table 78. Vital Therapies Inc Recent Development Table 79. Verlyx Pharma Inc Company Information Table 80. Verlyx Pharma Inc Business Overview Table 81. Verlyx Pharma Inc Alcoholic Hepatiti Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 82. Verlyx Pharma Inc Alcoholic Hepatiti Drug Product Portfolio Table 83. Verlyx Pharma Inc Recent Development Table 84. Promethera Biosciences SA Company Information Table 85. Promethera Biosciences SA Business Overview Table 86. Promethera Biosciences SA Alcoholic Hepatiti Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 87. Promethera Biosciences SA Alcoholic Hepatiti Drug Product Portfolio Table 88. Promethera Biosciences SA Recent Development Table 89. Intercept Pharmaceuticals Inc Company Information Table 90. Intercept Pharmaceuticals Inc Business Overview Table 91. Intercept Pharmaceuticals Inc Alcoholic Hepatiti Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 92. Intercept Pharmaceuticals Inc Alcoholic Hepatiti Drug Product Portfolio Table 93. Intercept Pharmaceuticals Inc Recent Development Table 94. Immuron Ltd Company Information Table 95. Immuron Ltd Business Overview Table 96. Immuron Ltd Alcoholic Hepatiti Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 97. Immuron Ltd Alcoholic Hepatiti Drug Product Portfolio Table 98. Immuron Ltd Recent Development Table 99. GRI Bio Inc Company Information Table 100. GRI Bio Inc Business Overview Table 101. GRI Bio Inc Alcoholic Hepatiti Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 102. GRI Bio Inc Alcoholic Hepatiti Drug Product Portfolio Table 103. GRI Bio Inc Recent Development Table 104. Gilead Sciences Inc Company Information Table 105. Gilead Sciences Inc Business Overview Table 106. Gilead Sciences Inc Alcoholic Hepatiti Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 107. Gilead Sciences Inc Alcoholic Hepatiti Drug Product Portfolio Table 108. Gilead Sciences Inc Recent Development Table 109. Generon (Shanghai) Corp Ltd Company Information Table 110. Generon (Shanghai) Corp Ltd Business Overview Table 111. Generon (Shanghai) Corp Ltd Alcoholic Hepatiti Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 112. Generon (Shanghai) Corp Ltd Alcoholic Hepatiti Drug Product Portfolio Table 113. Generon (Shanghai) Corp Ltd Recent Development Table 114. Alfact Innovation Company Information Table 115. Alfact Innovation Business Overview Table 116. Alfact Innovation Alcoholic Hepatiti Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 117. Alfact Innovation Alcoholic Hepatiti Drug Product Portfolio Table 118. Alfact Innovation Recent Development Table 119. North America Alcoholic Hepatiti Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 120. North America Alcoholic Hepatiti Drug Sales by Country (2021-2026) & (k units) Table 121. North America Alcoholic Hepatiti Drug Sales Market Share by Country (2021-2026) Table 122. North America Alcoholic Hepatiti Drug Sales Forecast by Country (2027-2032) & (k units) Table 123. North America Alcoholic Hepatiti Drug Sales Market Share Forecast by Country (2027-2032) Table 124. North America Alcoholic Hepatiti Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 125. North America Alcoholic Hepatiti Drug Market Size by Country (2021-2026) & (US$ Million) Table 126. North America Alcoholic Hepatiti Drug Market Share by Country (2021-2026) Table 127. North America Alcoholic Hepatiti Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 128. North America Alcoholic Hepatiti Drug Market Share Forecast by Country (2027-2032) Table 129. Europe Alcoholic Hepatiti Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 130. Europe Alcoholic Hepatiti Drug Sales by Country (2021-2026) & (k units) Table 131. Europe Alcoholic Hepatiti Drug Sales Market Share by Country (2021-2026) Table 132. Europe Alcoholic Hepatiti Drug Sales Forecast by Country (2027-2032) & (k units) Table 133. Europe Alcoholic Hepatiti Drug Sales Market Share Forecast by Country (2027-2032) Table 134. Europe Alcoholic Hepatiti Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 135. Europe Alcoholic Hepatiti Drug Market Size by Country (2021-2026) & (US$ Million) Table 136. Europe Alcoholic Hepatiti Drug Market Share by Country (2021-2026) Table 137. Europe Alcoholic Hepatiti Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 138. Europe Alcoholic Hepatiti Drug Market Share Forecast by Country (2027-2032) Table 139. Asia-Pacific Alcoholic Hepatiti Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 140. Asia-Pacific Alcoholic Hepatiti Drug Sales by Country (2021-2026) & (k units) Table 141. Asia-Pacific Alcoholic Hepatiti Drug Sales Market Share by Country (2021-2026) Table 142. Asia-Pacific Alcoholic Hepatiti Drug Sales Forecast by Country (2027-2032) & (k units) Table 143. Asia-Pacific Alcoholic Hepatiti Drug Sales Market Share Forecast by Country (2027-2032) Table 144. Asia-Pacific Alcoholic Hepatiti Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 145. Asia-Pacific Alcoholic Hepatiti Drug Market Size by Country (2021-2026) & (US$ Million) Table 146. Asia-Pacific Alcoholic Hepatiti Drug Market Share by Country (2021-2026) Table 147. Asia-Pacific Alcoholic Hepatiti Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 148. Asia-Pacific Alcoholic Hepatiti Drug Market Share Forecast by Country (2027-2032) Table 149. Latin America Alcoholic Hepatiti Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 150. Latin America Alcoholic Hepatiti Drug Sales by Country (2021-2026) & (k units) Table 151. Latin America Alcoholic Hepatiti Drug Sales Market Share by Country (2021-2026) Table 152. Latin America Alcoholic Hepatiti Drug Sales Forecast by Country (2027-2032) & (k units) Table 153. Latin America Alcoholic Hepatiti Drug Sales Market Share Forecast by Country (2027-2032) Table 154. Latin America Alcoholic Hepatiti Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 155. Latin America Alcoholic Hepatiti Drug Market Size by Country (2021-2026) & (US$ Million) Table 156. Latin America Alcoholic Hepatiti Drug Market Share by Country (2021-2026) Table 157. Latin America Alcoholic Hepatiti Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 158. Latin America Alcoholic Hepatiti Drug Market Share Forecast by Country (2027-2032) Table 159. Middle East and Africa Alcoholic Hepatiti Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 160. Middle East and Africa Alcoholic Hepatiti Drug Sales by Country (2021-2026) & (k units) Table 161. Middle East and Africa Alcoholic Hepatiti Drug Sales Market Share by Country (2021-2026) Table 162. Middle East and Africa Alcoholic Hepatiti Drug Sales Forecast by Country (2027-2032) & (k units) Table 163. Middle East and Africa Alcoholic Hepatiti Drug Sales Market Share Forecast by Country (2027-2032) Table 164. Middle East and Africa Alcoholic Hepatiti Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 165. Middle East and Africa Alcoholic Hepatiti Drug Market Size by Country (2021-2026) & (US$ Million) Table 166. Middle East and Africa Alcoholic Hepatiti Drug Market Share by Country (2021-2026) Table 167. Middle East and Africa Alcoholic Hepatiti Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 168. Middle East and Africa Alcoholic Hepatiti Drug Market Share Forecast by Country (2027-2032) Table 169. Key Raw Materials Table 170. Raw Materials Key Suppliers Table 171. Alcoholic Hepatiti Drug Distributors List Table 172. Alcoholic Hepatiti Drug Customers List Table 173. Research Programs/Design for This Report Table 174. Authors List of This Report Table 175. Secondary Sources Table 176. Primary Sources List of Figures Figure 1. Alcoholic Hepatiti Drug Image Figure 2. Global Alcoholic Hepatiti Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Alcoholic Hepatiti Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Alcoholic Hepatiti Drug Sales (2021-2032) & (k units) Figure 5. IMM-124E Image Figure 6. Global IMM-124E Sales YoY Growth (2021-2032) & (k units) Figure 7. HepaStem Image Figure 8. Global HepaStem Sales YoY Growth (2021-2032) & (k units) Figure 9. GRI-0621 Image Figure 10. Global GRI-0621 Sales YoY Growth (2021-2032) & (k units) Figure 11. F-652 Image Figure 12. Global F-652 Sales YoY Growth (2021-2032) & (k units) Figure 13. Others Image Figure 14. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 15. Global Alcoholic Hepatiti Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Alcoholic Hepatiti Drug Market Share by Type 2025 VS 2032 Figure 17. North America Alcoholic Hepatiti Drug Sales Market Share in Volume by Type in 2025 Figure 18. North America Alcoholic Hepatiti Drug Sales Market Share in Value by Type in 2025 Figure 19. Europe Alcoholic Hepatiti Drug Sales Market Share in Volume by Type in 2025 Figure 20. Europe Alcoholic Hepatiti Drug Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Alcoholic Hepatiti Drug Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Alcoholic Hepatiti Drug Sales Market Share in Value by Type in 2025 Figure 23. Latin America Alcoholic Hepatiti Drug Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Alcoholic Hepatiti Drug Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Alcoholic Hepatiti Drug Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Alcoholic Hepatiti Drug Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Alcoholic Hepatiti Drug Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Clinic Image Figure 30. Global Clinic Sales YoY Growth (2021-2032) & (k units) Figure 31. Hospital Image Figure 32. Global Hospital Sales YoY Growth (2021-2032) & (k units) Figure 33. Others Image Figure 34. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 35. Global Alcoholic Hepatiti Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Alcoholic Hepatiti Drug Market Share by Application 2025 VS 2032 Figure 37. North America Alcoholic Hepatiti Drug Sales Market Share in Volume by Application in 2025 Figure 38. North America Alcoholic Hepatiti Drug Sales Market Share in Value by Application in 2025 Figure 39. Europe Alcoholic Hepatiti Drug Sales Market Share in Volume by Application in 2025 Figure 40. Europe Alcoholic Hepatiti Drug Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Alcoholic Hepatiti Drug Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Alcoholic Hepatiti Drug Sales Market Share in Value by Application in 2025 Figure 43. Latin America Alcoholic Hepatiti Drug Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Alcoholic Hepatiti Drug Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Alcoholic Hepatiti Drug Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Alcoholic Hepatiti Drug Sales Market Share in Value by Application in 2025 Figure 47. North America Alcoholic Hepatiti Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. North America Alcoholic Hepatiti Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Alcoholic Hepatiti Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Alcoholic Hepatiti Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Alcoholic Hepatiti Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Europe Alcoholic Hepatiti Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Alcoholic Hepatiti Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Alcoholic Hepatiti Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Alcoholic Hepatiti Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Asia-Pacific Alcoholic Hepatiti Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Alcoholic Hepatiti Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Alcoholic Hepatiti Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Alcoholic Hepatiti Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 60. Latin America Alcoholic Hepatiti Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Alcoholic Hepatiti Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Alcoholic Hepatiti Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Alcoholic Hepatiti Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 64. Middle East and Africa Alcoholic Hepatiti Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Alcoholic Hepatiti Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Alcoholic Hepatiti Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Alcoholic Hepatiti Drug Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Alcoholic Hepatiti Drug Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • IMM-124E
  • HepaStem
  • GRI-0621
  • F-652
  • Others
Applications
  • Clinic
  • Hospital
  • Others
Companies covered
  • Vital Therapies Inc
  • Verlyx Pharma Inc
  • Promethera Biosciences SA
  • Intercept Pharmaceuticals Inc
  • Immuron Ltd
  • GRI Bio Inc
  • Gilead Sciences Inc
  • Generon (Shanghai) Corp Ltd
  • Alfact Innovation

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Alcoholic Hepatiti Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Alcoholic Hepatiti Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Alcoholic Hepatiti Drug Market by Type
  6. 1.3.1 IMM-124E
  7. 1.3.2 HepaStem
  8. 1.3.3 GRI-0621
  9. 1.3.4 F-652
  10. 1.3.5 Others
  11. 1.4 Global Alcoholic Hepatiti Drug Market Size by Type
  12. 1.4.1 Global Alcoholic Hepatiti Drug Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Alcoholic Hepatiti Drug Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Alcoholic Hepatiti Drug Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Alcoholic Hepatiti Drug Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Alcoholic Hepatiti Drug Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Alcoholic Hepatiti Drug Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Alcoholic Hepatiti Drug Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Alcoholic Hepatiti Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Alcoholic Hepatiti Drug Industry Trends
  2. 2.2 Alcoholic Hepatiti Drug Industry Drivers
  3. 2.3 Alcoholic Hepatiti Drug Industry Opportunities and Challenges
  4. 2.4 Alcoholic Hepatiti Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Alcoholic Hepatiti Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by Alcoholic Hepatiti Drug Sales (2021-2026)
  3. 3.3 Global Top Players by Alcoholic Hepatiti Drug Price (2021-2026)
  4. 3.4 Global Alcoholic Hepatiti Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Alcoholic Hepatiti Drug Major Company Production Sites & Headquarters
  6. 3.6 Global Alcoholic Hepatiti Drug Company, Product Type & Application
  7. 3.7 Global Alcoholic Hepatiti Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Alcoholic Hepatiti Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Alcoholic Hepatiti Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Alcoholic Hepatiti Drug Tier 1, Tier 2, and Tier 3
4 Alcoholic Hepatiti Drug Regional Status and Outlook
  1. 4.1 Global Alcoholic Hepatiti Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Alcoholic Hepatiti Drug Historic Market Size by Region
  3. 4.2.1 Global Alcoholic Hepatiti Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Alcoholic Hepatiti Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Alcoholic Hepatiti Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Alcoholic Hepatiti Drug Forecasted Market Size by Region
  7. 4.3.1 Global Alcoholic Hepatiti Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Alcoholic Hepatiti Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Alcoholic Hepatiti Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Alcoholic Hepatiti Drug by Application
  1. 5.1 Alcoholic Hepatiti Drug Market by Application
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Others
  5. 5.2 Global Alcoholic Hepatiti Drug Market Size by Application
  6. 5.2.1 Global Alcoholic Hepatiti Drug Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Alcoholic Hepatiti Drug Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Alcoholic Hepatiti Drug Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Alcoholic Hepatiti Drug Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Alcoholic Hepatiti Drug Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Alcoholic Hepatiti Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Alcoholic Hepatiti Drug Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Alcoholic Hepatiti Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Vital Therapies Inc
  2. 6.1.1 Vital Therapies Inc Company Information
  3. 6.1.2 Vital Therapies Inc Business Overview
  4. 6.1.3 Vital Therapies Inc Alcoholic Hepatiti Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Vital Therapies Inc Alcoholic Hepatiti Drug Product Portfolio
  6. 6.1.5 Vital Therapies Inc Recent Developments
  7. 6.2 Verlyx Pharma Inc
  8. 6.2.1 Verlyx Pharma Inc Company Information
  9. 6.2.2 Verlyx Pharma Inc Business Overview
  10. 6.2.3 Verlyx Pharma Inc Alcoholic Hepatiti Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Verlyx Pharma Inc Alcoholic Hepatiti Drug Product Portfolio
  12. 6.2.5 Verlyx Pharma Inc Recent Developments
  13. 6.3 Promethera Biosciences SA
  14. 6.3.1 Promethera Biosciences SA Company Information
  15. 6.3.2 Promethera Biosciences SA Business Overview
  16. 6.3.3 Promethera Biosciences SA Alcoholic Hepatiti Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Promethera Biosciences SA Alcoholic Hepatiti Drug Product Portfolio
  18. 6.3.5 Promethera Biosciences SA Recent Developments
  19. 6.4 Intercept Pharmaceuticals Inc
  20. 6.4.1 Intercept Pharmaceuticals Inc Company Information
  21. 6.4.2 Intercept Pharmaceuticals Inc Business Overview
  22. 6.4.3 Intercept Pharmaceuticals Inc Alcoholic Hepatiti Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Intercept Pharmaceuticals Inc Alcoholic Hepatiti Drug Product Portfolio
  24. 6.4.5 Intercept Pharmaceuticals Inc Recent Developments
  25. 6.5 Immuron Ltd
  26. 6.5.1 Immuron Ltd Company Information
  27. 6.5.2 Immuron Ltd Business Overview
  28. 6.5.3 Immuron Ltd Alcoholic Hepatiti Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Immuron Ltd Alcoholic Hepatiti Drug Product Portfolio
  30. 6.5.5 Immuron Ltd Recent Developments
  31. 6.6 GRI Bio Inc
  32. 6.6.1 GRI Bio Inc Company Information
  33. 6.6.2 GRI Bio Inc Business Overview
  34. 6.6.3 GRI Bio Inc Alcoholic Hepatiti Drug Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 GRI Bio Inc Alcoholic Hepatiti Drug Product Portfolio
  36. 6.6.5 GRI Bio Inc Recent Developments
  37. 6.7 Gilead Sciences Inc
  38. 6.7.1 Gilead Sciences Inc Company Information
  39. 6.7.2 Gilead Sciences Inc Business Overview
  40. 6.7.3 Gilead Sciences Inc Alcoholic Hepatiti Drug Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Gilead Sciences Inc Alcoholic Hepatiti Drug Product Portfolio
  42. 6.7.5 Gilead Sciences Inc Recent Developments
  43. 6.8 Generon (Shanghai) Corp Ltd
  44. 6.8.1 Generon (Shanghai) Corp Ltd Company Information
  45. 6.8.2 Generon (Shanghai) Corp Ltd Business Overview
  46. 6.8.3 Generon (Shanghai) Corp Ltd Alcoholic Hepatiti Drug Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Generon (Shanghai) Corp Ltd Alcoholic Hepatiti Drug Product Portfolio
  48. 6.8.5 Generon (Shanghai) Corp Ltd Recent Developments
  49. 6.9 Alfact Innovation
  50. 6.9.1 Alfact Innovation Company Information
  51. 6.9.2 Alfact Innovation Business Overview
  52. 6.9.3 Alfact Innovation Alcoholic Hepatiti Drug Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Alfact Innovation Alcoholic Hepatiti Drug Product Portfolio
  54. 6.9.5 Alfact Innovation Recent Developments
7 North America by Country
  1. 7.1 North America Alcoholic Hepatiti Drug Sales by Country
  2. 7.1.1 North America Alcoholic Hepatiti Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Alcoholic Hepatiti Drug Sales by Country (2021-2026)
  4. 7.1.3 North America Alcoholic Hepatiti Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America Alcoholic Hepatiti Drug Market Size by Country
  6. 7.2.1 North America Alcoholic Hepatiti Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Alcoholic Hepatiti Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America Alcoholic Hepatiti Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Alcoholic Hepatiti Drug Sales by Country
  2. 8.1.1 Europe Alcoholic Hepatiti Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Alcoholic Hepatiti Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe Alcoholic Hepatiti Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Alcoholic Hepatiti Drug Market Size by Country
  6. 8.2.1 Europe Alcoholic Hepatiti Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Alcoholic Hepatiti Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe Alcoholic Hepatiti Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Alcoholic Hepatiti Drug Sales by Country
  2. 9.1.1 Asia-Pacific Alcoholic Hepatiti Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Alcoholic Hepatiti Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Alcoholic Hepatiti Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Alcoholic Hepatiti Drug Market Size by Country
  6. 9.2.1 Asia-Pacific Alcoholic Hepatiti Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Alcoholic Hepatiti Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Alcoholic Hepatiti Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Alcoholic Hepatiti Drug Sales by Country
  2. 10.1.1 South America Alcoholic Hepatiti Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Alcoholic Hepatiti Drug Sales by Country (2021-2026)
  4. 10.1.3 South America Alcoholic Hepatiti Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America Alcoholic Hepatiti Drug Market Size by Country
  6. 10.2.1 South America Alcoholic Hepatiti Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Alcoholic Hepatiti Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America Alcoholic Hepatiti Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Alcoholic Hepatiti Drug Sales by Country
  2. 11.1.1 Middle East and Africa Alcoholic Hepatiti Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Alcoholic Hepatiti Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Alcoholic Hepatiti Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Alcoholic Hepatiti Drug Market Size by Country
  6. 11.2.1 Middle East and Africa Alcoholic Hepatiti Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Alcoholic Hepatiti Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Alcoholic Hepatiti Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Alcoholic Hepatiti Drug Value Chain Analysis
  2. 12.1.1 Alcoholic Hepatiti Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Alcoholic Hepatiti Drug Production Mode & Process
  7. 12.2 Alcoholic Hepatiti Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Alcoholic Hepatiti Drug Distributors
  10. 12.2.3 Alcoholic Hepatiti Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst